Fabry disease can be detected using a new magnetic resonance imaging (MRI) technique that was developed at the University of Alberta. The discovery of this new diagnostic tool has resulted in updated clinical guidelines for the diagnosis and treatment of Fabry disease in Canada.

Infinitt will introduce its new “Communicator” package at RSNA 2013. It is an add-on that ensures immediate communication of critical test results, provides peer review and emergency room discrepancy management and includes an embedded communication feature that allows real-time collaboration between users of the Infinitt picture archive and communications system (PACS). This is particularly valuable for clarification between the study’s dictating physician and transcriptionist or the referring physician.

Hologic, Inc., a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, announced that Jack W. Cumming, Hologic's president and CEO, presided over the NASDAQ Stock Market Opening Bell Ceremony on Oct. 1, marking the start of a month-long effort to raise awareness of breast cancer and the importance of breast cancer screening. This is the eighth year that Hologic has been selected to participate in the NASDAQ opening bell ceremonies celebrating the start of Breast Cancer Awareness Month.

The North Shore-LIJ Health System Department of Radiation Medicine presented a study to evaluate the reliability of different systems used by caregivers to assess toxicity for patients receiving radiation therapy at the 55th Annual Meeting of the American Society of Therapeutic Radiation Oncology (ASTRO).

Civco Medical Solutions demonstrated the integration between the Protura Robotic Patient Positioning System and Varian’s Clinac iX and Trilogy medical linear accelerators via the Varian Motion Management Interface at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Proton therapy is the most advanced radiation technique available. Unfortunately, access to proton therapy is limited due to the low number of proton therapy centers. Research institutes and hospitals are now frequently investing in proton therapy to make it more accessible to patients.

Results of EORTC trial 10853 appearing in Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ (DCIS). In the European Organisation for Research and Treatment of Cancer (EORTC) study, adjuvant radiotherapy after local excision reduced the incidence of both in situ and invasive local recurrences by a factor of two and resulted in an overall lower risk of mastectomy.

The Thayer School of Engineering and Geisel School of Medicine at Dartmouth together with LI-COR Biosciences and Affibody AB announced a new partnership to establish an efficient pipeline for development and translation of molecularly targeted agents. The National Cancer Institute funds the five-year project.

Terry Fox clinical trial/study CT systems computer-aided detection lung cancer

A Terry Fox Research Institute(TFRI)-led study developed a new clinical risk calculator software that classifies, 9 out of 10 times, which spots or lesions (nodules) are benign and malignant on an initial lung computed tomography (CT) scan among individuals at high risk for lung cancer.

Elekta unveiled a state-of-the-art learning center at its North American headquarters, in conjunction with the 55th Annual Meeting of the American Society for Radiation Oncology (ASTRO), which was held in Atlanta.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now